1	Have been treated with felbamate or vigabatrin within the 6 months prior to Screening If a subject has been previously treated with vigabatrin 6 months prior to Screening a visual perimetry test performed within 6 months prior to Screening must show normal visual fields or no worsening of recognized|felbamate[23,32]|||||||||C0060135|24812|24812|felbamate
1	Have been treated with felbamate or vigabatrin within the 6 months prior to Screening If a subject has been previously treated with vigabatrin 6 months prior to Screening a visual perimetry test performed within 6 months prior to Screening must show normal visual fields or no worsening of recognized|vigabatrin[36,46]|||||||6 months[58,66]||C0048044|14851|14851|vigabatrin
1	Have been treated with felbamate or vigabatrin within the 6 months prior to Screening If a subject has been previously treated with vigabatrin 6 months prior to Screening a visual perimetry test performed within 6 months prior to Screening must show normal visual fields or no worsening of recognized|vigabatrin[132,142]|||||||6 months[143,151]||C0048044|14851|14851|vigabatrin
2	visual field abnormalities as compared with prior to vigabatrin treatment|vigabatrin[354,364]|||||||||C0048044|14851|14851|vigabatrin
